AZD9592: Data from P1 EGRET trial (NCT05647122) for advanced solid tumors/NSCLC/HNSCC/CRC in H2 2025 (AstraZeneca) - Aug 1, 2024 - H1 & Q2 2024 Results
P1 data • Colorectal Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma of Head and Neck
|